The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Items 101–200 of 785
Genetics of familial and sporadic pancreatic cancer
Wood, L. D., Yurgelun, M. B., & Goggins, M. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.039 · Cited by 91
Self-citationGenomic and fragmentomic landscapes of cell-free DNA for early cancer detection
Bruhm, D. C., Vulpescu, N. A., Foda, Z. H., Phallen, J. A., Scharpf, R. B., & Velculescu, V. E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00795-x · Cited by 110
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma
Brand, R. E., Borazanci, E. H., Speare, V., Dudley, B., Karloski, E., Peters, M. L. B., Stobie, L., Bahary, N., Zeh, H. J., Zureikat, A. H., et al. (2018) · Cancer · doi:10.1002/cncr.31628 · Cited by 88
Serrão, E. M., Kettunen, M. I., Rodrigues, T. B., Dzien, P., Wright, A. J., Gopinathan, A., Gallagher, F. A., Lewis, D. Y., Frese, K. K., Almeida, J., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310114 · Cited by 87
Kim, H., Saka, B., Knight, S., Borges, M. W., Childs, E. J., Klein, A. P., Wolfgang, C. L., Herman, J. M., Adsay, V. N., Hruban, R. H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1239 · Cited by 88
Self-citationEmerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Neeße, A., Gress, T. M., Tuveson, D. A., Michl, P., & Krug, S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38111 · Cited by 87
Are there still indications for total pancreatectomy?
Chiaro, M. D., Rangelova, E. B., Segersvärd, R., & Arnelo, U. (2016) · Updates in Surgery · doi:10.1007/s13304-016-0388-6 · Cited by 85
Boland, C. R., Idos, G., Durno, C. A., Giardiello, F. M., Anderson, J. C., Burke, C. A., Dominitz, J. A., Gross, S. A., Gupta, S. N., Jacobson, B. C., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.021 · Cited by 85
Yabar, C. S., & Winter, J. M. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.04.003 · Cited by 85
Greenhalf, W., Lévy, P., Gress, T. M., Rebours, V., Brand, R. E., Pandol, S., Chari, S. T., Jørgensen, M. T., Mayerle, J. V., Lerch, M. M., et al. (2020) · Pancreatology · doi:10.1016/j.pan.2020.05.011 · Cited by 83
Canto, M. I., Kerdsirichairat, T., Yeo, C. J., Hruban, R. H., Shin, E. J., Almario, J. A., Blackford, A. L., Ford, M., Klein, A. P., Javed, A. A., et al. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04230-z · Cited by 82
Self-citationSuenaga, M., Yu, J., Shindo, K., Tamura, K., Almario, J. A., Zaykoski, C., Witmer, P. D., Fesharakizadeh, S., Borges, M., Lennon, A.-M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2463 · Cited by 81
Self-citationAdvances in pancreatic cancer research: Moving towards early detection
He, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11241 · Cited by 80
Endoscopic ultrasound (EUS) and the management of pancreatic cancer
Yousaf, M. N., Chaudhary, F. S., Ehsan, A., Suarez, A. L., Muniraj, T., Jamidar, P. A., Aslanian, H. R., & Farrell, J. J. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000408 · Cited by 81
Refinement of screening for familial pancreatic cancer
Bartsch, D. K., Slater, E. P., Carrato, A., Ibrahim, I. S., Guillen-Ponce, C., Vasen, H. F. A., Matthäi, E., Earl, J., Jendryschek, F. S., Figiel, J., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311098 · Cited by 85
Natural history of SPINK1 germline mutation related-pancreatitis
Müller, N., Sarantitis, I., Rouanet, M., de Mestier, L., Halloran, C. M., Greenhalf, W., Férec, C., Masson, E., Ruszniewski, P. B., Lévy, P., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.032 · Cited by 74
Fusaroli, P., Serrani, M., GIORGIO, R. D., D’Ercole, M. C., Ceroni, L., Lisotti, A., & Caletti, G. G. (2015) · Pancreas · doi:10.1097/mpa.0000000000000441 · Cited by 73
Chronic Pancreatitis: Epidemiology, Diagnosis, and Management Updates
Kichler, A., & Jang, S. N. (2020) · Drugs · doi:10.1007/s40265-020-01360-6 · Cited by 73
Clinical practice guideline: Acute and chronic pancreatitis
Beyer, G., Hoffmeister, A., Lorenz, P., Lynen, P., Lerch, M. M., & Mayerle, J. V. (2022) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0223 · Cited by 81
Lucas, A. L., Shakya, R., Lipsyc, M. D., Mitchel, E. B., Kumar, S., Hwang, C., Deng, L., DeVoe, C., Chabot, J. A., Szabolcs, M. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3020 · Cited by 69
Hereditary melanoma: Update on syndromes and management
Soura, E., Eliades, P. J., Shannon, K., Stratigos, A., & Tsao, H. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.08.037 · Cited by 74
Lucas, A. L., Frado, L. E., Hwang, C., Kumar, S., Khanna, L. G., Levinson, E. J., Chabot, J. A., Chung, W. K., & Frucht, H. (2014) · Cancer · doi:10.1002/cncr.28662 · Cited by 68
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
Galeotti, A. A., Gentiluomo, M., Rizzato, C., Obazee, O. M., Neoptolemos, J. P., Pasquali, C., Nentwich, M. F., Cavestro, G. M., Pezzilli, R., Greenhalf, W., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-106961 · Cited by 71
Paiella, S., Salvia, R., Pastena, M. D., Pollini, T., Casetti, L., Landoni, L., Esposito, A., Marchegiani, G., Malleo, G., Marchi, G. D., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2018.04.002 · Cited by 71
Self-citationThe Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer
Kimura, H., Klein, A. P., Hruban, R. H., & Roberts, N. J. (2021) · Pancreas · doi:10.1097/mpa.0000000000001888 · Cited by 65
Self-citationFamilial skin cancer syndromes
Ransohoff, K. J., Jaju, P., Tang, J. Y., Carbone, M., Leachman, S. A., & Sarin, K. Y. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.09.070 · Cited by 71
Vangala, D., Cauchin, E., Balmañà, J., Wyrwicz, L. S., Cutsem, E. V., Güller, U., Castells, A., Carneiro, F., Hammel, P. R., Ducreux, M. P., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.09.004 · Cited by 66
Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis
Corral, J. E., Das, A., Bruno, M. J., & Wallace, M. B. (2019) · Pancreas · doi:10.1097/mpa.0000000000001268 · Cited by 66
Self-citationClinical and pathologic features of familial pancreatic cancer
Humphris, J. L., Johns, A. L., Simpson, S. H., Cowley, M. J., Pajic, M., Chang, D. K.-F., Nagrial, A. M., Chin, V. T., Chantrill, L. A., Pinese, M., et al. (2014) · Cancer · doi:10.1002/cncr.28863 · Cited by 65
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
Graffeo, R., Livraghi, L., Pagani, O., Goldhirsch, A., Partridge, A. H., & Garber, J. E. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4003-9 · Cited by 69
Current Approaches to Pancreatic Cancer Screening
Chhoda, A., Lu, L., Clerkin, B. M., Risch, H. A., & Farrell, J. J. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.09.013 · Cited by 64
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
Piombino, C., Cortesi, L., Lambertini, M., Punie, K., Grandi, G., & Toss, A. (2020) · Journal of Oncology · doi:10.1155/2020/6384190 · Cited by 63
Jøergensen, M. T., Gerdes, A., Sørensen, J. R., de Muckadell, O. B. S., & Mortensen, M. B. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.013 · Cited by 63
Klatte, D. C. F., Wallace, M. B., Löhr, M. J., Bruno, M. J., & van Leerdam, M. E. (2022) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2021.101783 · Cited by 68
Self-citationSignoretti, M., Bruno, M. J., Zerboni, G., Poley, J., Fave, G. D., & Capurso, G. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640617752182 · Cited by 62
Self-citationShams, R., Saberi, S., Zali, M. R., Sadeghi, A., Ghafouri‐Fard, S., & Aghdaei, H. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-64569-1 · Cited by 65
Long, N. P., Yoon, S. J., Anh, N. H., Nghi, T. D., Lim, D. K., Hong, Y. J., Hong, S., & Kwon, S. W. (2018) · Metabolomics · doi:10.1007/s11306-018-1404-2 · Cited by 62
Michl, P., Löhr, M. J., Neoptolemos, J. P., Capurso, G., Rebours, V., Malats, N., Ollivier, M., & Ricciardiello, L. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12123 · Cited by 60
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
Hu, C., LaDuca, H., Shimelis, H., Polley, E. C., Lilyquist, J., Hart, S. N., Na, J., Thomas, A., Lee, K. Y., Davis, B. T., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00291 · Cited by 57
Pancreatic cancer in Lynch syndrome patients
Bujanda, L., & Herreros-Villanueva, M. (2017) · Journal of Cancer · doi:10.7150/jca.20750 · Cited by 57
Farr, K. P., Moses, D. A., Haghighi, K. S., Phillips, P. A., Hillenbrand, C. M., & Chua, B. H. (2022) · Cancers · doi:10.3390/cancers14102539 · Cited by 57
Familial skin cancer syndromes
Jaju, P. D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.08.073 · Cited by 57
Appelbaum, L., Cambronero, J., Stevens, J. P., Horng, S., Pollick, K., Silva, G., Haneuse, S., Piatkowski, G., Benhaga, N., Duey, S., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.10.019 · Cited by 55
Giardiello, F. M., Allen, J. I., Axilbund, J. E., Boland, C. R., Burke, C. A., Burt, R. W., Church, J. M., Dominitz, J. A., Johnson, D. A., Kaltenbach, T. R., et al. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.06.006 · Cited by 56
Pancreatic cancer screening in high-risk individuals with germline genetic mutations
Davee, T. R., Coronel, E. S., Papafragkakis, C., Thaiudom, S., Lanke, G., Chakinala, R. C., Nogueras‐González, G. M., Bhutani, M. S., Ross, W. A., Weston, B. R., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.12.019 · Cited by 56
Ohmoto, A., Yachida, S., & Morizane, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030561 · Cited by 58
The role of endoscopic ultrasound in pancreatic cancer screening
Bhutani, M., Koduru, P., Joshi, V., Saxena, P., Suzuki, R., Irisawa, A., & Yamao, K. (2016) · Endoscopic Ultrasound · doi:10.4103/2303-9027.175876 · Cited by 55
Familial pancreatic adenocarcinoma
Petersen, G. M. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.04.007 · Cited by 53
Midha, S., Sreenivas, V., Kabra, M., Chattopadhyay, T. K., Joshi, Y. K., & Garg, P. K. (2016) · Pancreas · doi:10.1097/mpa.0000000000000684 · Cited by 54
Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer
Kato, S., & Honda, K. (2020) · Cancers · doi:10.3390/cancers12071965 · Cited by 56
Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma
Sharma, G. G., Okada, Y., Hoff, D. D. V., & Goel, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.001 · Cited by 54
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
Self-citationThe Role of Genetics in Pancreatitis
Hasan, A., Moscoso, D. I., & Kastrinos, F. (2018) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2018.06.001 · Cited by 54
Screening for Pancreatic Cancer
Lucas, A. L., & Kastrinos, F. (2019) · JAMA · doi:10.1001/jama.2019.9690 · Cited by 52
Screening and early detection of pancreatic cancer in high risk population
Chang, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2358 · Cited by 52
Shin, E. J., Topazian, M. D., Goggins, M., Syngal, S., Saltzman, J. R., Lee, J. H., Farrell, J. J., & Canto, M. I. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.02.028 · Cited by 52
Self-citationBerliner, J. L., Cummings, S. A., Burnett, B. B., & Ricker, C. N. (2021) · Journal of Genetic Counseling · doi:10.1002/jgc4.1374 · Cited by 55
Effective screening for early diagnosis of pancreatic cancer
Hanada, K., Okazaki, A., Hirano, N., Izumi, Y., Minami, T., Ikemoto, J., Kanemitsu, K., & Hino, F. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.09.017 · Cited by 51
A cost analysis of a pancreatic cancer screening protocol in high-risk populations
Bruenderman, E., & Martin, R. C. G. (2015) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.11.017 · Cited by 51
Fabbri, C., Luigiano, C., Maimone, A., Tarantino, I., Baccarini, P., Fornelli, A., Liotta, R., Polifemo, A., Barresi, L., Traina, M., et al. (2014) · Surgical Endoscopy · doi:10.1007/s00464-014-3846-6 · Cited by 51
Paiella, S., Capurso, G., Cavestro, G. M., Butturini, G., Pezzilli, R., Salvia, R., Signoretti, M., Crippa, S., Carrara, S., Frigerio, I. M., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0414-z · Cited by 51
Self-citationStrategies for early detection of resectable pancreatic cancer
Okano, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11230 · Cited by 50
Benzel, J., & Fendrich, V. (2018) · Oncology Research and Treatment · doi:10.1159/000493473 · Cited by 53
Dumonceau, J., Delhaye, M., Charette, N., & Farina, A. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820927292 · Cited by 52
Risk Factors and Therapeutic Targets in Pancreatic Cancer
Wörmann, S. M., & Algül, H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00282 · Cited by 51
Technological advances for the detection of melanoma
Fried, L., Tan, A., Bajaj, S., Liebman, T. N., Polsky, D., & Stein, J. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.03.121 · Cited by 49
Epidemiology and Risk Factors of Pancreatic Cancer
Molinari, M., Liu, H., & Kaltenmeier, C. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109778 · Cited by 49
Germline mutations in pancreatic cancer and potential new therapeutic options
Pihlak, R., Valle, J. W., & McNamara, M. G. (2017) · Oncotarget · doi:10.18632/oncotarget.17291 · Cited by 48
Pittman, M. E., Rao, R. A., & Hruban, R. H. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0426-ra · Cited by 49
Self-citationFamilial Pancreatic Cancer: Current Perspectives
Llach, J., Carballal, S., & Moreira, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s172421 · Cited by 51
Dbouk, M., Brewer Gutierrez, O. I., Lennon, A. M., Chuidian, M., Shin, E. J., Kamel, I. R., Fishman, E. K., He, J., Burkhart, R. A., Wolfgang, C. L., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.017 · Cited by 46
Self-citationAn Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
Huang, X., Chi, H., Gou, S., Guo, X., Li, L., Peng, G., Zhang, J., Xu, J., Nian, S., & Yuan, Q. (2023) · Genes · doi:10.3390/genes14010124 · Cited by 48
Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA
Haan, D., Bergamaschi, A., Friedl, V., Guler, G. D., Ning, Y., Reggiardo, R. E., Kesling, M., Collins, M., Gibb, B., Hazen, K., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.03.016 · Cited by 47
PanGen-Fam: Spanish registry of hereditary pancreatic cancer
Mocci, E., Guillén‐Ponce, C., Earl, J., Márquez, M., Solera, J., Salazar-Lopez, M.-T., Calcedo-Arnáiz, C., Vázquez-Sequeiros, E., Montáns, J., Beltrán, M. M., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.004 · Cited by 47
Inherited mutations in DNA repair genes and cancer risk
Romero-Laorden, N., & Castro, E. (2017) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2017.02.009 · Cited by 47
Katabathina, V. S., Menias, C. O., Khanna, L., Murphy, L. M., Dasyam, A. K., Lubner, M. G., & Prasad, S. R. (2019) · Radiographics · doi:10.1148/rg.2019180185 · Cited by 47
Mirus, J. E., Zhang, Y., Li, C. I., Lokshin, A. E., Prentice, R. L., Hingorani, S. R., & Lampe, P. D. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3474 · Cited by 47
Goel, G., & Sun, W. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0141-5 · Cited by 46
Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size
Hur, C., Tramontano, A. C., Dowling, E. C., Brooks, G. A., Jeon, A., Brugge, W. R., Gazelle, G. S., Kong, C. Y., & Pandharipande, P. V. (2015) · Pancreas · doi:10.1097/mpa.0000000000000587 · Cited by 48
Bergeron, J., Perry, K., Houser, P. M., & Yang, J. Z. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21497 · Cited by 45
Gonda, T. A., Everett, J. N., Wallace, M. B., Simeone, D. M., Amundadottir, L. T., Beyer, G., Bi, Y., Brentnall, T. A., Carpizo, D. R., Carrato, A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.036 · Cited by 45
Épidémiologie du cancer du pancréas
Drouillard, A., Manfrédi, S., Lepage, C., & Bouvier, A. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.11.004 · Cited by 49
Burk, K. S., Knipp, D., & Sahani, D. V. (2018) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2018.03.006 · Cited by 44
Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer
Yoshida, T., Yamashita, Y., & Kitano, M. (2019) · Diagnostics · doi:10.3390/diagnostics9030081 · Cited by 45
Computer-Aided Diagnosis and Staging of Pancreatic Cancer Based on CT Images
Li, M., Nie, X., Reheman, Y., Huang, P., Zhang, S., Yuan, Y., Chen, C., Yan, Z., Chen, C., Lv, X., et al. (2020) · IEEE Access · doi:10.1109/access.2020.3012967 · Cited by 44
A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection
Dumstrei, K., Chen, H., & Brenner, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7098 · Cited by 43
Chen, F., Roberts, N. J., & Klein, A. P. (2017) · Chinese Clinical Oncology · doi:10.21037/cco.2017.12.04 · Cited by 42
Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro, P., Macedo, G., & Melo, S. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00779 · Cited by 43
Harrington, K. A., Shukla‐Dave, A., Paudyal, R., & Do, R. K. G. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27148 · Cited by 42
Targeted Screening of Individuals at High Risk for Pancreatic Cancer: Results of a Simulation Model
Pandharipande, P. V., Heberle, C. R., Dowling, E. C., Kong, C. Y., Tramontano, A. C., Perzan, K. E., Brugge, W. R., & Hur, C. (2014) · Radiology · doi:10.1148/radiol.14141282 · Cited by 41
Cremin, C., Lee, M. K. C., Hong, Q., Hoeschen, C., Mackenzie, A., Dixon, K., McCullum, M., Nuk, J., Kalloger, S. E., Karasinska, J. M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2973 · Cited by 41
Bannon, S. A., Montiel, M. F., Goldstein, J. B., Dong, W., Mork, M. E., Borras, E., Hasanov, M., Varadhachary, G. R., Maitra, A., Katz, M. H., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0014 · Cited by 40
Hidalgo, M. M., Álvarez-Gallego, R., Gallego-Plazas, J., Guillén‐Ponce, C., Laquente, B., Macarulla, T. M., Muñoz, A., Salgado, M., Vera, R., Adeva, J., et al. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1594-x · Cited by 40
Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma
Unger, K. R., Mehta, K. Y., Kaur, P., Wang, Y., Menon, S. S., Jain, S. K., Moonjelly, R. A., Suman, S., Datta, K., Singh, R., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25212 · Cited by 43
Molecular landscape of Hereditary Melanoma
Arnaut, J. R. M. B., Guimarães, I. D. S., dos Santos, A. C. E., da Silva, F. D. M. L., Machado, J. R. D. S., & de Melo, A. C. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103425 · Cited by 41
Jia, K., Kundrot, S., Palchuk, M. B., Warnick, J., Haapala, K., Kaplan, I. D., Rinard, M., & Appelbaum, L. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104888 · Cited by 40
Cannistrà, M., Ruggiero, M., Zullo, A., Serafini, S., Grande, R., & Nardo, B. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.04.093 · Cited by 38
Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9
Jawad, Z., Theodorou, I. G., Jiao, L. R., & Xie, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-14688-z · Cited by 40
Metastatic pancreatic cancer: Mechanisms and detection (Review)
Chen, X., Liu, F., Xue, Q., Weng, X., & Xu, F. (2021) · Oncology Reports · doi:10.3892/or.2021.8182 · Cited by 38
Li, J., Li, Y., Chen, C., Guo, J., Qiao, M., & Lyu, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1049136 · Cited by 38
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
